These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 27869886)
1. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients]. Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886 [TBL] [Abstract][Full Text] [Related]
2. ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure. Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M Eur Heart J Suppl; 2017 May; 19(Suppl D):D102-D112. PubMed ID: 28751838 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides in heart failure and acute coronary syndrome. Gaggin HK; Januzzi JL Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786 [TBL] [Abstract][Full Text] [Related]
5. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Ibrahim N; Januzzi JL Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. Clerico A; Passino C; Franzini M; Emdin M Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers in heart failure: the past, current and future. Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637 [TBL] [Abstract][Full Text] [Related]
8. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure. Gruson D; Ahn SA; Rousseau MF Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303 [TBL] [Abstract][Full Text] [Related]
9. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Motiwala SR; Januzzi JL Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878 [TBL] [Abstract][Full Text] [Related]
10. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. Francis GS; Felker GM; Tang WH J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients]. Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Palazzuoli A; Masson S; Ronco C; Maisel A Heart Fail Rev; 2014 Mar; 19(2):267-84. PubMed ID: 23563622 [TBL] [Abstract][Full Text] [Related]
13. Which biomarkers do clinicians need for diagnosis and management of heart failure with reduced ejection fraction? Pouleur AC Clin Chim Acta; 2015 Mar; 443():9-16. PubMed ID: 25447693 [TBL] [Abstract][Full Text] [Related]